Datametrex Graph Blockchain Announces Collaboration Agreement With Revive Therapeutics to Develop a Patient Data Blockchain Platform
TORONTO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV:DM) (FSE:D4G) is pleased to announce that its subsidiary company Graph Blockchain Limited has signed a Collaboration Agreement with Revive Therapeutics Ltd. ("Revive") (TSXV:RVV) (OTCQB:RVVTF) to develop the blockchain component in Revive’s proprietary patient-focused program enabled by artificial intelligence (“AI”) dedicated to the medical cannabis industry.
This agreement is in addition to the previously announced contract between Nexalogy and Revive on November 27, where Nexalogy will use its proprietary social data discovery solution, NexaIntelligence, to unlock the value of data related to medical cannabis collected from social media networks and internet environments such as discussion forums, blogs and news sites.
“The collaboration with Graph Blockchain complements our current relationship with Datametrex’s AI subsidiary, Nexalogy, and is an important piece of our plan in building our concept of a patient-focused platform enabled by AI for the medical cannabis industry,” said Fabio Chianelli, President of Revive.
Andrew Ryu, Chairman and CEO of Datametrex AI stated, “We are thrilled to sign a second contract with Revive and look forward to developing a complete package of Blockchain and Artificial Intelligence solutions for them. This is an explosive area and our solutions will assist Revive in delivering vital data for patients. We are in talks with a number of Marijuana Licensed Producers and see an opportunity for Datametrex AI and Graph Blockchain solutions to become the leader in providing these solutions for the Cannabis sector.”
About Revive Therapeutics Ltd.
Revive Therapeutics Ltd. is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and pharmaceutical sectors.
